The wound care adhesives market is stratified by adhesive chemistry, which dictates performance, cost, and adoption across clinical settings. Acrylic‑based adhesives, characterized by rapid polymerization and high tensile strength, dominate the volume segment, accounting for roughly 40 % of total sales due to their suitability for high‑stress surgical closures. Silicone‑based adhesives, prized for low tissue reactivity and gentle removal, capture about 25 % of the market, driven by increasing use in pediatric and geriatric populations where minimizing trauma is critical. Hydrocolloid adhesives, which combine a moisture‑retentive matrix with an adhesive layer, represent 15 % of revenue, primarily in chronic wound management where exudate control is essential. Polyurethane adhesives, offering flexibility and breathability, contribute 12 % and are favored in burn and traumatic injury dressings. Emerging bio‑adhesive formulations—often protein‑based or peptide‑crosslinked—hold a nascent 8 % share but are projected to accelerate as regenerative‑medicine applications mature.